These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1893 related items for PubMed ID: 9506190
1. Type II diabetes mellitus. Edelman SV. Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [Abstract] [Full Text] [Related]
2. Insulin therapy in type 2 diabetes. Mudaliar S, Edelman SV. Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406 [Abstract] [Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ, Bailey CJ. Drugs; 2005 Dec; 65(3):385-411. PubMed ID: 15669880 [Abstract] [Full Text] [Related]
4. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Porte D. Diabetes Metab Res Rev; 2001 Dec; 17(3):181-8. PubMed ID: 11424231 [Abstract] [Full Text] [Related]
5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL, Figgitt DP. Pharmacoeconomics; 2004 Dec; 22(6):389-411. PubMed ID: 15099124 [Abstract] [Full Text] [Related]
7. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes. Caballero AE. J Diabetes Complications; 2009 May; 23(2):143-52. PubMed ID: 18413192 [Abstract] [Full Text] [Related]
8. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. Cosmi F, Cosmi D. G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871 [Abstract] [Full Text] [Related]
9. Pharmacologic therapy for type 2 diabetes mellitus. DeFronzo RA. Ann Intern Med; 1999 Aug 17; 131(4):281-303. PubMed ID: 10454950 [Abstract] [Full Text] [Related]
10. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study). Weinrauch LA, D'Elia JA, Finn P, Lewis EF, Desai AS, Claggett BL, Cooper ME, McGill JB. Diabetes Res Clin Pract; 2016 Mar 17; 113():143-51. PubMed ID: 26830074 [Abstract] [Full Text] [Related]
11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS. Diabetes Care; 1995 Aug 17; 18(8):1113-23. PubMed ID: 7587846 [Abstract] [Full Text] [Related]
12. How to fight obesity with antidiabetic drugs: targeting gut or kidney? Baretić M, Troskot R. Minerva Endocrinol; 2015 Mar 17; 40(1):71-83. PubMed ID: 25366984 [Abstract] [Full Text] [Related]
13. Improving glycaemic control with current therapies. Birkeland KI. Diabet Med; 1998 Mar 17; 15 Suppl 4():S13-9. PubMed ID: 9868986 [Abstract] [Full Text] [Related]
14. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes; 1995 Nov 17; 44(11):1249-58. PubMed ID: 7589820 [Abstract] [Full Text] [Related]
15. Non-insulin-dependent (type II) diabetes mellitus. Rodger W. CMAJ; 1991 Dec 15; 145(12):1571-81. PubMed ID: 1742694 [Abstract] [Full Text] [Related]
16. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Chan JL, Abrahamson MJ. Mayo Clin Proc; 2003 Apr 15; 78(4):459-67. PubMed ID: 12683698 [Abstract] [Full Text] [Related]
17. Managing type 2 diabetes: going beyond glycemic control. Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. J Manag Care Pharm; 2008 Jun 15; 14(5 Suppl B):s2-19. PubMed ID: 18597582 [Abstract] [Full Text] [Related]
18. [Treatment of diabetes in metabolic syndrome]. Pelikánova T. Vnitr Lek; 2009 Jun 15; 55(7-8):637-45. PubMed ID: 19731868 [Abstract] [Full Text] [Related]
19. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus. Standl E, Füchtenbusch M. Diabetologia; 2003 Mar 15; 46 Suppl 1():M30-6. PubMed ID: 12652356 [Abstract] [Full Text] [Related]
20. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Lebovitz HE. Cleve Clin J Med; 2002 Oct 15; 69(10):809-20. PubMed ID: 12371804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]